JAZIRA SULTANOVA: Open Payments
NPI 1508238221 · MCHENRY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$220 in 11 payments from 7 companies in 2025. Trend: 2023 $13 · 2024 $45 · 2025 $220
Food & beverage: $220
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $76 |
| Lundbeck LLC | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Alkermes, Inc. | 1 | $15 |
| Tris Pharma Inc | 1 | $15 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
Products named: INGREZZA, REXULTI, Auvelity, AUSTEDO XR, LYBALVI, Dyanavel XR, Relexxii.
Industry payments across IL — which companies pay providers there.
